{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:55:06Z","timestamp":1794084906252,"version":"4.8.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ebiom.2021.103780","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T18:44:24Z","timestamp":1640285064000},"page":"103780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":274,"special_numbering":"C","title":["Clinical tools and biomarkers to predict preeclampsia"],"prefix":"10.1016","volume":"75","author":[{"given":"Teresa M","family":"MacDonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan P","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6233-9737","authenticated-orcid":false,"given":"Tu'uhevaha J","family":"Kaitu'u-Lino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2021.103780_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)32335-7","article-title":"Pre-eclampsia","author":"Chappell","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103780_bib0002","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103780_bib0003","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103780_bib0004","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"issue":"8433","key":"10.1016\/j.ebiom.2021.103780_bib0005","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0140-6736(85)92207-X","article-title":"Prevention of pre-eclampsia by early antiplatelet therapy","volume":"1","author":"Beaufils","year":"1985","journal-title":"Lancet"},{"issue":"9575","key":"10.1016\/j.ebiom.2021.103780_bib0006","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103780_bib0007","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103780_bib0008","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ajog.2018.02.014","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit","volume":"218","author":"Wright","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"10204","key":"10.1016\/j.ebiom.2021.103780_bib0009","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0140-6736(19)31963-4","article-title":"Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial","volume":"394","author":"Chappell","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0011","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"Low-Dose Aspirin Use During Pregnancy","volume":"132","year":"2018","journal-title":"Obstetrics and gynecology"},{"key":"10.1016\/j.ebiom.2021.103780_bib0012","doi-asserted-by":"crossref","first-page":"c2207","DOI":"10.1136\/bmj.c2207","article-title":"Management of hypertensive disorders during pregnancy: summary of NICE guidance","volume":"341","author":"Visintin","year":"2010","journal-title":"Bmj"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103780_bib0013","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan","year":"2018","journal-title":"Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103780_bib0014","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/ajo.12499","article-title":"Management of pregnancies complicated by hypertensive disorders of pregnancy: Could we do better?","volume":"57","author":"Helou","year":"2017","journal-title":"The Australian & New Zealand journal of obstetrics & gynaecology"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103780_bib0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/uog.14819","article-title":"Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening","volume":"46","author":"Park","year":"2015","journal-title":"Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology"},{"key":"10.1016\/j.ebiom.2021.103780_bib0016","article-title":"Cost effectiveness analysis of a model of first trimester prediction and prevention for preterm preeclampsia against usual care","author":"Park","year":"2020","journal-title":"Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103780_bib0017","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/1471-0528.16361","article-title":"Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study","volume":"128","author":"Guy","year":"2021","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103780_bib0018","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/uog.19076","article-title":"Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia","volume":"53","author":"Ortved","year":"2019","journal-title":"Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0019","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice","volume":"72","author":"Brown","year":"1979","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/uog.20105","article-title":"ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia","volume":"53","author":"Sotiriadis","year":"2019","journal-title":"Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103780_bib0021","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2013.08.019","article-title":"Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease","volume":"209","author":"Lisonkova","year":"2013","journal-title":"American journal of obstetrics and gynecology"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103780_bib0022","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1471-0528.2005.00565.x","article-title":"Outcomes of severe pre-eclampsia\/eclampsia in Yorkshire 1999\/2003","volume":"112","author":"Tuffnell","year":"2005","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103780_bib0023","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/AOG.0b013e31823311c1","article-title":"Incidence, risk factors, and associated complications of eclampsia","volume":"118","author":"Liu","year":"2011","journal-title":"Obstetrics and gynecology"},{"issue":"19","key":"10.1016\/j.ebiom.2021.103780_bib0024","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ebiom.2021.103780_bib0025","article-title":"Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction","author":"McLaughlin","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ebiom.2021.103780_bib0026","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.preghy.2020.10.005","article-title":"Placental growth factor measurements in the assessment of women with suspected Preeclampsia: A stratified analysis of the PARROT trial","volume":"23","author":"Duhig","year":"2021","journal-title":"Pregnancy hypertension"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103780_bib0027","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/1471-0528.15855","article-title":"Placental growth factor testing for suspected pre-eclampsia: a cost-effectiveness analysis","volume":"126","author":"Duhig","year":"2019","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0028","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/uog.19051","article-title":"Comparison of three commercially available placental growth factor-based tests in women with suspected preterm pre-eclampsia: the COMPARE study","volume":"53","author":"McCarthy","year":"2019","journal-title":"Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology"},{"key":"10.1016\/j.ebiom.2021.103780_bib0029","article-title":"Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia","author":"Tong","year":"2020","journal-title":"American journal of obstetrics and gynecology"},{"key":"10.1016\/j.ebiom.2021.103780_bib0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.placenta.2020.01.008","article-title":"A review of omics approaches to study preeclampsia","volume":"92","author":"Benny","year":"2020","journal-title":"Placenta"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103780_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11080530","article-title":"Do Mass Spectrometry-Derived Metabolomics Improve the Prediction of Pregnancy-Related Disorders? Findings from a UK Birth Cohort with Independent Validation","volume":"11","author":"McBride","year":"2021","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0032","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ije\/dyz098","article-title":"4-Hydroxyglutamate is a novel predictor of pre-eclampsia","volume":"49","author":"Sovio","year":"2020","journal-title":"Int J Epidemiol"},{"issue":"16","key":"10.1016\/j.ebiom.2021.103780_bib0033","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020302","article-title":"Circulating Growth Differentiation Factor 15 Is Increased Preceding Preeclampsia Diagnosis: Implications as a Disease Biomarker","volume":"10","author":"Cruickshank","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103780_bib0034","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0002-9378(99)70239-5","article-title":"Preeclampsia: an excessive maternal inflammatory response to pregnancy","volume":"180","author":"Redman","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"5728","key":"10.1016\/j.ebiom.2021.103780_bib0035","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103780_bib0036","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1210\/jc.2011-1233","article-title":"Measurement of mRNA transcripts of very high placental expression in maternal blood as biomarkers of preeclampsia","volume":"96","author":"Paiva","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103780_bib0037","doi-asserted-by":"crossref","first-page":"e78487","DOI":"10.1371\/journal.pone.0078487","article-title":"Circulating MicroRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero","volume":"8","author":"Whitehead","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0038","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41598-018-36645-0","article-title":"Circulating GATA2 mRNA is decreased among women destined to develop preeclampsia and may be of endothelial origin","volume":"9","author":"Whigham","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2021.103780_bib0039","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.preghy.2019.02.003","article-title":"Circulating adrenomedullin mRNA is decreased in women destined to develop term preeclampsia","volume":"16","author":"Whigham","year":"2019","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0040","doi-asserted-by":"crossref","first-page":"18077","DOI":"10.1038\/s41598-020-73783-w","article-title":"MicroRNAs 363 and 149 are differentially expressed in the maternal circulation preceding a diagnosis of preeclampsia","volume":"10","author":"Whigham","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2021.103780_bib0041","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.placenta.2021.01.018","article-title":"Circulating Tissue Factor Pathway Inhibitor (TFPI) is increased preceding preeclampsia diagnosis and in established preeclampsia","volume":"105","author":"MacDonald","year":"2021","journal-title":"Placenta"},{"key":"10.1016\/j.ebiom.2021.103780_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2019.09.010","article-title":"Death associated protein kinase 1 (DAPK-1) is increased in preeclampsia","volume":"88","author":"Yung","year":"2019","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103780_bib0043","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nm1530","article-title":"Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection","volume":"13","author":"Lo","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2021.103780_bib0044","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1196\/annals.1368.012","article-title":"Placental RNA in maternal plasma: toward noninvasive fetal gene expression profiling","volume":"1075","author":"Tsui","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ebiom.2021.103780_bib0045","first-page":"123","article-title":"Molecular analysis of circulating RNA in plasma","volume":"336","author":"Tsui","year":"2006","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0046","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1038\/s41467-021-22695-y","article-title":"The RNA landscape of the human placenta in health and disease","volume":"12","author":"Gong","year":"2021","journal-title":"Nat Commun"},{"issue":"14","key":"10.1016\/j.ebiom.2021.103780_bib0047","doi-asserted-by":"crossref","first-page":"e25294","DOI":"10.1097\/MD.0000000000025294","article-title":"Identification and validation of key non-coding RNAs and mRNAs using co-expression network analysis in pre-eclampsia","volume":"100","author":"He","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ebiom.2021.103780_bib0048","article-title":"Identification of Key Genes and Long Noncoding RNA-Associated Competing Endogenous RNA (ceRNA) Networks in Early-Onset Preeclampsia","volume":"2020","author":"Zhang","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ebiom.2021.103780_bib0049","first-page":"1","article-title":"Maternal whole blood mRNA signatures identify women at risk of early preeclampsia: a longitudinal study","author":"Tarca","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ebiom.2021.103780_bib0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.placenta.2019.02.002","article-title":"The untapped potential of placenta-enriched molecules for diagnostic and therapeutic development","volume":"84","author":"Whigham","year":"2019","journal-title":"Placenta"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103780_bib0051","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/jog.14397","article-title":"Levels of serum Hoxb3 and sFlt-1 in pre-eclamptic patients and their effects on pregnancy outcomes","volume":"46","author":"Zhou","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0052","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-020-01605-x","article-title":"Circulating mRNAs are differentially expressed in pregnancies with severe placental insufficiency and at high risk of stillbirth","volume":"18","author":"Hannan","year":"2020","journal-title":"BMC Med"},{"issue":"18","key":"10.1016\/j.ebiom.2021.103780_bib0053","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1093\/hmg\/ddq272","article-title":"The primate-specific microRNA gene cluster (C19MC) is imprinted in the placenta","volume":"19","author":"Noguer-Dance","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103780_bib0054","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20122972","article-title":"The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs","volume":"20","author":"Hromadnikova","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103780_bib0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40291-020-00468-5","article-title":"Circulating Nucleic Acids in Maternal Plasma and Serum in Pregnancy Complications: Are They Really Useful in Clinical Practice?","volume":"24","author":"Carbone","year":"2020","journal-title":"A Systematic Review. Mol Diagn Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0056","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/uog.20117","article-title":"Prediction of pre-eclampsia: review of reviews","volume":"54","author":"Townsend","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ebiom.2021.103780_bib0057","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.placenta.2019.04.005","article-title":"The association between first trimester AFP to PAPP-A ratio and placentally-related adverse pregnancy outcome","volume":"81","author":"Hughes","year":"2019","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103780_bib0058","first-page":"308","article-title":"Second-trimester Maternal Serum Screening Biomarkers in the Risk Assessment for Preeclampsia","volume":"48","author":"Long","year":"2018","journal-title":"Ann Clin Lab Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0059","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12884-020-2789-2","article-title":"First-trimester maternal serum alpha-fetoprotein is not a good predictor for adverse pregnancy outcomes: a retrospective study of 3325 cases","volume":"20","author":"Hu","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"issue":"21","key":"10.1016\/j.ebiom.2021.103780_bib0060","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103780_bib0061","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/oxfordjournals.jbchem.a021798","article-title":"Human cDNA encoding a novel TGF-beta superfamily protein highly expressed in placenta","volume":"122","author":"Yokoyama-Kobayashi","year":"1997","journal-title":"J Biochem"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103780_bib0062","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-05-4067","article-title":"Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer","volume":"66","author":"Bauskin","year":"2006","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0063","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","article-title":"Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease","volume":"63","author":"Wollert","year":"2017","journal-title":"Clinical chemistry"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103780_bib0064","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/uog.22070","article-title":"Second- and third-trimester serum levels of growth-differentiation factor-15 in prediction of pre-eclampsia","volume":"56","author":"Wertaschnigg","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103780_bib0065","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ajog.2019.11.1286","article-title":"Early-onset preeclampsia, plasma microRNAs, and endothelial cell function","volume":"222","author":"Lip","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ebiom.2021.103780_bib0066","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.bi.63.070194.001135","article-title":"Nitric oxide: a physiologic messenger molecule","volume":"63","author":"Bredt","year":"1994","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0067","first-page":"19","article-title":"Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice","volume":"77","author":"Liu","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ebiom.2021.103780_bib0068","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.placenta.2018.07.010","article-title":"Asymmetric dimethylarginine levels in preeclampsia - Systematic review and meta-analysis","volume":"69","author":"Nemeth","year":"2018","journal-title":"Placenta"},{"issue":"27","key":"10.1016\/j.ebiom.2021.103780_bib0069","doi-asserted-by":"crossref","first-page":"43944","DOI":"10.18632\/oncotarget.16543","article-title":"Circulating asymmetric dimethylarginine and the risk of preeclampsia: a meta-analysis based on 1338 participants","volume":"8","author":"Yuan","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103780_bib0070","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1753944715624853","article-title":"The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia","volume":"10","author":"Saleh","year":"2016","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103780_bib0071","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/uog.17561","article-title":"Prediction of severe pre-eclampsia\/HELLP syndrome by combination of sFlt-1, CT-pro-ET-1 and blood pressure: exploratory study","volume":"51","author":"Lind Malte","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0072","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000491087","article-title":"Placental Proinflammatory State and Maternal Endothelial Dysfunction in Preeclampsia","volume":"84","author":"Valencia-Ortega","year":"2019","journal-title":"Gynecol Obstet Invest"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103780_bib0073","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ekir.2019.03.012","article-title":"Diagnostic indicators of superimposed preeclampsia in women with CKD","volume":"4","author":"Wiles","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ebiom.2021.103780_bib0074","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.preghy.2021.02.010","article-title":"Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease","volume":"24","author":"Wiles","year":"2021","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103780_bib0075","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20193219","article-title":"Circulating endocan and preeclampsia: a meta-analysis","volume":"40","author":"Lan","year":"2020","journal-title":"Biosci Rep"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421005740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421005740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:15:49Z","timestamp":1762456549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421005740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":75,"alternative-id":["S2352396421005740"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103780","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical tools and biomarkers to predict preeclampsia","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103780"}}